Avenir Corp - ABBVIE INC ownership

ABBVIE INC's ticker is ABBV and the CUSIP is 00287Y109. A total of 3,120 filers reported holding ABBVIE INC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.


AbbVie Inc. is a pharmaceutical company that specializes in the development and commercialization of innovative medicines. The company was founded in 2013 and is headquartered in North Chicago, Illinois. AbbVie's mission is to improve the lives of people around the world by providing them with access to high-quality, safe, and effective medicines.

AbbVie's portfolio of products includes some of the world's most widely used and recognized medicines. These include Humira, a treatment for rheumatoid arthritis, psoriasis, and other autoimmune diseases, and Imbruvica, a treatment for certain types of cancer. The company also has a strong pipeline of new products in development, including treatments for Alzheimer's disease, Parkinson's disease, and other conditions.

AbbVie is committed to sustainability and social responsibility. The company has set ambitious goals to reduce its environmental impact, including reducing greenhouse gas emissions and water usage. AbbVie also supports a range of charitable organizations and initiatives, including those focused on improving access to healthcare and education.

In conclusion, AbbVie Inc. is a leading pharmaceutical company that is dedicated to improving the lives of people around the world. With a strong portfolio of products and a commitment to sustainability and social responsibility, AbbVie is well-positioned for continued success in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Avenir Corp ownership history of ABBVIE INC
Q3 2023$217,926
Q1 2023$232,999
Q4 2022$236,274
Q2 2022$224,000
Q1 2022$237,0001,4620.02%
Other shareholders
ABBVIE INC shareholders Q4 2022
NameSharesValueWeighting ↓
PARK CIRCLE Co 72,495$10,806,10510.13%
swisspartners Advisors Ltd 83,098$11,340,6639.97%
Prairie Sky Financial Group LLC 82,558$12,306,1378.66%
Bruce & Co., Inc. 163,000$24,296,7808.28%
D. SCOTT NEAL, INC. 58,573$8,730,8297.46%
Tri Locum Partners LP 144,561$21,548,2636.89%
TSFG, LLC 127,965$19,0756.80%
INSPIRION WEALTH ADVISORS, LLC 211,486$31,524,0426.15%
Agate Pass Investment Management, LLC 56,680$8,448,7215.73%
View complete list of ABBVIE INC shareholders